LIU Yang, ZHANG Zhiping, PENG Daorong, SONG Liuwei, GE Shengxiang, HAO Xiaoke, LIU Jiayun. Establishment and performance evaluation of chemiluminescent microparticle immunoassay for the determination of high concentration HbsAg[J]. Laboratory Medicine, 2020, 35(10): 1056-1061.
LEE J,KIM M,CHAE H,et al.Evaluation of enzymatic BM test HbA1 c on the JCA-BM6010/C and comparison with Bio-Rad Variant Ⅱ Turbo,Tosoh HLC 723 G8,and AutoLab immunoturbidimetry assay[J]. Clin Chem Lab Med,2013,51(11):2201-2208.
[4]
Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative ensurement procedures[S]. EP6-A,CLSI,2003.
[5]
Clinical and Laboratory Standards Institute. User verification of performance for precision and trueness[S]. EP15-A2,CLSI,2005.
[6]
Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantitative measurement methods[S]. EP5-A2,CLSI,2004.
[7]
Clinical and Laboratory Standards Institute. Interference testing in clinical chemistry[S]. EP7-A2,CLSI,2005.
[8]
WANG F S,FAN J G,ZHANG Z,et al.The global burden of liver disease:the major impact of China[J]. Hepatology,2014,60(6):2099-2108.
[9]
ZEISEL M B,LUCIFORA J,MASON W S,et a1.Towards an HBV cure:state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure[J].Gut,2015,64(8):1314-1326.
[10]
World Health Organization.Guidelines for the prevention,care and treatment of persons with chronic hepatitis B infection[R]. Geneva:WHO,2015.
[11]
LAMPERTICO P,MAINI M,PAPATHEODORIDIS G.Optimal management of hepatitis B virus infection -EASL special conference[J]. J Hepatol,2015,63(5):1238-1253.
[12]
俞莹卿. 第二代化学发光试剂检测乙肝表面抗原的多中心评估[D]. 上海:复旦大学,2011.
[13]
WURSTHORM K,JAROSZEWICZ J,ZACHER B J,et al.Correlation between the Elecsys HBsAg Ⅱ assay and the Architect assay for the quantification of hepatitis B surface antigen(HBsAg) in the serum[J]. J Clin Virol,2011,50(4):292-296.